BROWSE

Related Researcher

Author

Park, Tae Joo
Developmental Morphogenesis Lab
Research Interests
  • Morphogenesis, chondrogenesis, ciliogenesis

ITEM VIEW & DOWNLOAD

3′-Sialyllactose protects against osteoarthritic development by facilitating cartilage homeostasis

Cited 0 times inthomson ciCited 0 times inthomson ci
Title
3′-Sialyllactose protects against osteoarthritic development by facilitating cartilage homeostasis
Author
Jeon, JiminKang, Li-JungLee, Kwang MinCho, ChanmiSong, Eun KyungKim, WookPark, Tae JooYang, Siyoung
Issue Date
201801
Publisher
WILEY-BLACKWELL
Citation
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, v.22, no.1, pp.57 - 66
Abstract
3′-Sialyllactose has specific physiological functions in a variety of tissues; however, its effects on osteoarthritic development remain unknown. Here, we demonstrated the function of 3′-sialyllactose on osteoarthritic cartilage destruction. In vitro and ex vivo, biochemical and histological analysis demonstrated that 3′-sialyllactose was sufficient to restore the synthesis of Col2a1 and accumulation of sulphated proteoglycan, a critical factor for cartilage regeneration in osteoarthritic development, and blocked the expression of Mmp3, Mmp13 and Cox2 induced by IL-1β, IL-6, IL-17 and TNF-α, which mediates cartilage degradation. Further, reporter gene assays revealed that the activity of Sox9 as a transcription factor for Col2a1 expression was accelerated by 3′-sialyllactose, whereas the direct binding of NF-κB to the Mmp3, Mmp13 and Cox2 promoters was reduced by 3′-sialyllactose in IL-1β-treated chondrocytes. Additionally, IL-1β induction of Erk phosphorylation and IκB degradation, representing a critical signal pathway for osteoarthritic development, was totally blocked by 3′-sialyllactose in a dose-dependent manner. In vivo, 3′-sialyllactose protected against osteoarthritic cartilage destruction in an osteoarthritis mouse model induced by destabilization of the medial meniscus, as demonstrated by histopathological analysis. Our results strongly suggest that 3′-sialyllactose may ameliorate osteoarthritic cartilage destruction by cartilage regeneration via promoting Col2a1 production and may inhibit cartilage degradation and inflammation by suppressing Mmp3, Mmp13 and Cox2 expression. The effects of 3′-sialyllactose could be attributed in part to its regulation of Sox9 or NF-κB and inhibition of Erk phosphorylation and IκB degradation. Taken together, these effects indicate that 3′-sialyllactose merits consideration as a natural therapeutic agent for protecting against osteoarthritis.
URI
Go to Link
DOI
http://dx.doi.org/10.1111/jcmm.13292
ISSN
1582-4934
Appears in Collections:
SLS_Journal Papers

find_unist can give you direct access to the published full text of this article. (UNISTARs only)

Show full item record

qr_code

  • mendeley

    citeulike

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

MENU